1. Home
  2. FHB vs DNLI Comparison

FHB vs DNLI Comparison

Compare FHB & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Hawaiian Inc.

FHB

First Hawaiian Inc.

HOLD

Current Price

$26.26

Market Cap

3.3B

Sector

Finance

ML Signal

HOLD

Logo Denali Therapeutics Inc.

DNLI

Denali Therapeutics Inc.

HOLD

Current Price

$18.68

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FHB
DNLI
Founded
1858
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
2.6B
IPO Year
2016
2017

Fundamental Metrics

Financial Performance
Metric
FHB
DNLI
Price
$26.26
$18.68
Analyst Decision
Hold
Strong Buy
Analyst Count
6
12
Target Price
$27.50
$30.82
AVG Volume (30 Days)
1.7M
1.8M
Earning Date
01-30-2026
02-27-2026
Dividend Yield
3.95%
N/A
EPS Growth
22.91
N/A
EPS
2.20
N/A
Revenue
$853,588,000.00
N/A
Revenue This Year
$6.97
N/A
Revenue Next Year
$3.70
$3,897.53
P/E Ratio
$11.95
N/A
Revenue Growth
7.53
N/A
52 Week Low
$20.32
$10.57
52 Week High
$28.35
$23.77

Technical Indicators

Market Signals
Indicator
FHB
DNLI
Relative Strength Index (RSI) 46.09 44.28
Support Level $26.54 $18.66
Resistance Level $27.42 $20.21
Average True Range (ATR) 0.85 1.39
MACD -0.13 -0.36
Stochastic Oscillator 28.61 3.10

Price Performance

Historical Comparison
FHB
DNLI

About FHB First Hawaiian Inc.

First Hawaiian Inc is a bank holding company. It provides a diversified range of banking services to consumer and commercial customers, including deposit products, lending services, and wealth management and trust services. The company offers a variety of deposit products to its customers, including checking and savings accounts and other types of deposit accounts. It provides commercial and industrial lending, including auto dealer flooring, commercial real estate, and construction lending. It also offers comprehensive consumer lending services focused on residential real estate lending, indirect auto financing, and other consumer loans. The company's segments are Retail Banking, Commercial Banking, and Treasury, and others of which key revenue is derived from Retail Banking.

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

Share on Social Networks: